315 related articles for article (PubMed ID: 27173443)
21. A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens.
Lu M; Xia ZY; Bao L
J Immunol Res; 2014; 2014():395626. PubMed ID: 24741595
[TBL] [Abstract][Full Text] [Related]
22. Inactivated
Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
Front Immunol; 2019; 10():1588. PubMed ID: 31354727
[TBL] [Abstract][Full Text] [Related]
23. Heterologous Boosting With
Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
Front Immunol; 2020; 11():2036. PubMed ID: 32983151
[TBL] [Abstract][Full Text] [Related]
24. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
25. Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis.
Ji P; Hu ZD; Kang H; Yuan Q; Ma H; Wen HL; Wu J; Li ZM; Lowrie DB; Fan XY
Immunol Res; 2016 Feb; 64(1):64-72. PubMed ID: 26111521
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
Lahey T; Laddy D; Hill K; Schaeffer J; Hogg A; Keeble J; Dagg B; Ho MM; Arbeit RD; von Reyn CF
PLoS One; 2016; 11(12):e0168521. PubMed ID: 27997597
[TBL] [Abstract][Full Text] [Related]
27. Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice.
Yang E; Gu J; Wang F; Wang H; Shen H; Chen ZW
Microb Pathog; 2016 Apr; 93():1-7. PubMed ID: 26792673
[TBL] [Abstract][Full Text] [Related]
28. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
29. Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.
Kang H; Yuan Q; Ma H; Hu ZD; Han DP; Wu K; Lowrie DB; Fan XY
Immunology; 2014 Dec; 143(4):661-9. PubMed ID: 24965530
[TBL] [Abstract][Full Text] [Related]
30. The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.
Hu Z; Gu L; Li CL; Shu T; Lowrie DB; Fan XY
Front Immunol; 2018; 9():1796. PubMed ID: 30123219
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
32. Boosting BCG with inert spores improves immunogenicity and induces specific IL-17 responses in a murine model of bovine tuberculosis.
Garcia-Pelayo MC; Kaveh DA; Sibly L; Webb PR; Bull NC; Cutting SM; Hogarth PJ
Tuberculosis (Edinb); 2016 May; 98():97-103. PubMed ID: 27156624
[TBL] [Abstract][Full Text] [Related]
33. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
34. The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity.
Billeskov R; Elvang TT; Andersen PL; Dietrich J
PLoS One; 2012; 7(6):e39909. PubMed ID: 22768165
[TBL] [Abstract][Full Text] [Related]
35. Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model.
Kwon KW; Lee A; Larsen SE; Baldwin SL; Coler RN; Reed SG; Cho SN; Ha SJ; Shin SJ
Sci Rep; 2019 Oct; 9(1):15560. PubMed ID: 31664157
[TBL] [Abstract][Full Text] [Related]
36. Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection.
Guerrero GG; Locht C
Clin Dev Immunol; 2011; 2011():730702. PubMed ID: 21647410
[TBL] [Abstract][Full Text] [Related]
37. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
38. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis].
Gao L; Bao L; Hao M; Zhang L; Qin ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487
[TBL] [Abstract][Full Text] [Related]
39. A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.
Rai PK; Chodisetti SB; Zeng W; Nadeem S; Maurya SK; Pahari S; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2017 Oct; 15(1):201. PubMed ID: 28985739
[TBL] [Abstract][Full Text] [Related]
40. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
